Trinity Biotech (TRIB) Revenue Growth (5y) (2014 - 2024)
Trinity Biotech (TRIB) Revenue Growth (5y) (2014 - 2024) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.64 Bn | 176.34 Bn | 6.27 Bn |
| 2 | Stryker | 129.04 Bn | 126.16 Bn | 3.81 Bn |
| 3 | Medtronic | 109.04 Bn | 99.82 Bn | 6.41 Bn |
| 4 | Boston Scientific | 68.54 Bn | 67.08 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 48.67 Bn | 45.00 Bn | 1.29 Bn |
| 6 | Dexcom | 28.40 Bn | 27.28 Bn | 750.30 Mn |
| 7 | GE HealthCare Technologies | 28.37 Bn | 26.08 Bn | 1.98 Bn |
| 8 | Smith & Nephew | 26.92 Bn | 26.34 Bn | - |
| 9 | Koninklijke Philips | 25.48 Bn | 22.36 Bn | 2.07 Bn |
| 10 | Trinity Biotech | 105.39 Mn | 100.25 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | -5.75% |
| Sep 30, 2024 | -9.23% |
| Jun 30, 2024 | -6.77% |
| Mar 31, 2024 | -7.76% |
| Dec 31, 2023 | -11.35% |
| Sep 30, 2023 | -9.15% |
| Jun 30, 2023 | -11.08% |
| Mar 31, 2023 | -9.03% |
| Dec 31, 2022 | -8.53% |
| Sep 30, 2022 | -9.31% |
| Jun 30, 2022 | -9.54% |
| Mar 31, 2022 | -7.81% |
| Dec 31, 2021 | -3.79% |
| Sep 30, 2021 | -3.38% |
| Jun 30, 2021 | -0.34% |
| Mar 31, 2021 | 1.71% |
| Dec 31, 2020 | 5.61% |
| Sep 30, 2020 | 4.44% |
| Jun 30, 2020 | -7.96% |
| Mar 31, 2020 | -3.45% |